Objective: Many factors that are associated with both clinical outcomes and pathogenesis of disease in cases of essential hypertension have been reported. One of these is uric acid. In this study, we aimed to investigate the relationship between serum and spot urine uric acid levels and red blood cell distribution width (RDW), mean platelet volume (MPV), and C-reactive protein (CRP) levels in patients with essential hypertension.
Introduction
The close relationship between uric acid and hypertension (HT) has been demonstrated both in experimental models and in clinical studies (1, 2) . It has been reported that although hyperuricemia is a known risk factor for HT, early treatment of hyperuricemia can help control blood pressure more easily and prevent cardiovascular complications secondary to HT (3, 4) .
Both HT and hyperuricemia are well-known risk factors for premature cardiovascular diseases (5, 6) . The relationship between the levels of serum uric acid, C-reactive protein (CRP), mean platelet volume (MPV), and red blood cell distribution width (RDW) and cardiovascular diseases has been revealed in various studies (6) (7) (8) (9) (10) (11) (12) (13) (14) . Many studies have shown that markers such as uric acid, high-sensitivity CRP (hsCRP), and RDW can be effective in predicting targeted organ damage.
In this study, we aimed to find the predictive value for the early detection of cardiovascular diseases using serum and spot urine uric acid, RDW, MPV, and CRP in hypertensive patients.
Methods

Patients
The study included patients who applied to the outpatient clinic of Internal Diseases and Cardiology between January 01, 2013, and December 31, 2013. The patients diagnosed with diabetes mellitus, heart failure, chronic kidney disease, paralysis, and chronic obstructive pulmonary disease were excluded from the study. After receiving approval from the Local Ethics Committee, 62 patients who agreed to participate in the study and signed the written informed consent form were enrolled. The patients were divided into two groups as those developing and not developing cardiovascular complications according to the results of echocardiography, stress test, and angiography.
The following were determined to be the cardiovascular complications: diastolic dysfunction, systolic dysfunction, ≥50% coronary stenosis, and low ejection fraction. The patients with the absence (group 1) and presence (group 2) of cardiovascular complications were identified. Laboratory parameters, blood pressure values, and length of HT were compared among the patients included in the study.
Samples
Uric acid parameters of the patients were studied with AD-VIA device using the enzymatic uricase/peroxidase method; MPV and RDW parameters were studied with ADVIA 2120i device and CRP parameters with ADVIA device using latexenhanced immunoturbidimetric method. Glomerular filtration rate (GFR) was calculated using modification of diet in renal disease (MDRD) formula (GFR=186´serum creatinine −1.154´age−0.203´gender ´race) (15) .
Statistical analysis
While evaluating the data obtained from the study, IBM Statistical for Package Social Sciences (SPSS IBM Corp; Armonk, NY, USA) Statistics 22.0 software was used for statistical analysis. Descriptive statistical methods (mean and standard deviation) were employed. In the between-group comparisons of quantitative data, Student's t-test was used for comparing normally distributed parameters. Non-normally distributed data were compared using Mann-Whitney U test. On the other hand, continuity correction (Yates) test and Fisher's exact test were employed for comparing the qualitative data. Diagnostic scanning tests were utilized in the calculation of specificity and sensitivity. The significance was evaluated at the level of p<0.05.
Results
Of all the patients included in our study, 39 (62.9%) (group 1) had no cardiovascular complication, whereas 23 (37.1%) (group 2) had the complications. The mean age of the patients was 51.09±8.62 (31-69) years. While the mean age was 50.15±8.13 years in Group 1, it was 52.69±9.36 years in Group 2, and no statistically significant difference was found between the groups in terms of mean ages (p>0.05). The mean systolic blood pressure (SBP) in Group 2 (150 mmHg) was significantly higher than that in Group 1 (140 mmHg) (p<0.05). The mean diastolic blood pressure (DBP) in Group 2 [90 mmHg (91.3±7.42)] was significantly higher than that in Group 1 [90 mmHg (86.54±8.36)] (p<0.05) (Table 1, Figure 1 ).
While there was a statistically significant difference between the groups with regard to cholesterol and triglyceride levels, no difference was detected with regard to low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol levels (p<0.05 and p>0.05, respectively).
The mean CRP level was 4.89 mg/L in Group 1 and 3.64 mg/L in Group 2. The mean RDW level was 13.8 RU in Group 1 and 13.5 RU in Group 2. The mean serum and spot urine uric acid levels of Group 1 were 5.57±1.23 mg/dL and 65.13±29.11 mg/dL, respectively; for Group 2, these values were 5.33±0.8 mg/dL and 61.94±18.13 mg/dL, respectively. A statistically significant difference was not found between the groups for all parameters (p>0.05) ( Table 2) .
A comparison of normal and abnormal values of CRP, uric acid, MPV, and RDW is presented in Table 3 . The measurement results of sensitivity of CRP, uric acid, MPV, and RDW values in the prediction of the disease are presented in Table  4 . Sensitivity and specificity were calculated based on normal In the evaluation of the effects of SBP, DBP, triglyceride, and cholesterol, which were found to be significant in univariate analyses, on the disease through logistic regression analysis, the model was revealed to be highly significant; Negelkerke R-square value was 0.228, and the model's coefficient of determination was at a good level (74.2%). However, the effect of any parameter on the model was not found to be statistically significant.
While there was no significant correlation among GFR, RDW, MPV, urine and blood uric acid, and CRP values in Group 1 (p=0.001), a statistically significant negative correlation was found between GFR and RDW in Group 2 (p<0.01). Similarly, there was a statistically significant positive correlation between CRP and RDW and a negative correlation between RDW and MPV in Group 2 (p=0.047; p<0.05, p=0.033; p<0.05, respectively) ( Table 5 ).
Discussion
As in many diseases, strict control of blood pressure and early detection of cardiovascular complications are highly important in the prevention of HT's cardiovascular complications. For this purpose, many serum and urine parameters should be investigated. In this study, the relationship among laboratory parameters that were investigated in 62 patients without any chronic disease except HT was examined in two groups as those developing and not developing cardiovascular complications.
As expected in our study, SBP and DBP were detected to be significant risk factors in terms of the development of cardiovascular complications in hypertensive patients. Banach et al. (16) found the rate of cardiovascular disease as 5.4% and reported a linear relationship between blood pressure and cardiovascular disease and all-cause mortality risk in different age groups.
In our study, there was no significant relationship between patient and control groups with regard to CRP, serum and spot urine uric acid, RDW, and MPV values, which are reported to be associated with different cardiovascular diseases in many studies. In literature, there are conflicting data on this issue. In many studies that were conducted for early prediction of targeted organ damage, hsCRP, RDW, and serum uric acid levels were generally found to be significant. The parameters examined in our study were also detected to be insignificant in the prediction of cardiovascular complications. In general, MPV and findings related to serum uric acid level found by some researchers were consistent with our study, but the findings on CRP and RDW were inconsistent. Insignificant result on CRP might have been due to that normal CRP levels were evaluated instead of hsCRP in our study, whereas hsCRP was used in other studies. We could not evaluate the effects of patient treatments for HT and/or comorbid conditions on all parameters because of insufficient data records, which can be considered as a limitation of our study.
Conclusion
In this study investigating the efficiency of serum and spot urine uric acid, CRP, RDW, and MPV levels in the prediction of cardiovascular diseases in essential hypertensive patients, no relationship was detected between the levels of serum and spot urine uric acid and MPV, CRP, and RDW, which display a close correlation with cardiovascular diseases. It was concluded that these parameters were not predictive for cardiovascular diseases. However, more comprehensive and prospective further studies are needed for reaching an acceptable result on this issue. Ethics Committee Approval: Ethics committee approval was received for this study from local ethics committee.
Informed Consent: Informed consent was obtained from patients who participated in this study. 
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